ARCHIVES

Cancergrams Cost $840 Year For All

This article is from The Cancer Letter archive.

Vol. 03 No. 48 | December 2, 1977

Download PDF Visit The Full Archive

Related Articles

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

FDA Approves Merck’s Gardasil Vaccine To Prevent Cervical Cancer.

June 9, 2006

Decision Delayed On Breast Cancer Study Until After Consensus Meeting

July 5, 1985

Letters From Ovarian Cancer Survivors Shed Light On Their Psychological Distress

October 31, 2003

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

November 23, 2005

Funding Opportunities

October 4, 2002